ALNY Jul 2024 155.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

24.50

-0.10

(-0.41%)

As of 10:40AM EDT. Market open.

Loading interactive chart…

Simply Wall St.
Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) Shift From Loss To Profit
With the business potentially at an important milestone, we thought we'd take a closer look at Alnylam Pharmaceuticals...
Business Wire
Alnylam Issues 2023 Corporate Responsibility Report
CAMBRIDGE, Mass., May 07, 2024--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today the publication of its 2023 Corporate Responsibility Report. The company continues to take meaningful steps across each of its six corporate responsibility pillars. This year’s edition expands data disclosures across each pillar and highlights examples of the company’s commitment to ensuring patient access, reducing health inequities, and being a responsible stewar
Simply Wall St.
The Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) First-Quarter Results Are Out And Analysts Have Published New Forecasts
Alnylam Pharmaceuticals, Inc. ( NASDAQ:ALNY ) just released its latest first-quarter results and things are looking...